U.S. Army Quietly Developing Hantavirus Vaccines and Gene Therapies

More details emerge on hantavirus patients on cruise ship | CIDRAP

This article originally appeared on Focal Points and was republished with permission.

Guest post by Nicolas Hulscher, MPH

As a cruise ship outbreak unfolds, the U.S. Army’s “needle-free” DNA gene therapy platforms come into focus.

While the mass media breathlessly covers the MV Hondius — a Dutch-flagged expedition ship now quarantined off Cape Verde with multiple confirmed hantavirus cases — few are aware that there are currently 13 documented hantavirus vaccine and gene therapy programs in active development:

6 DNA “vaccines” (US Army / USAMRIID) — many of them “needle-free” jet-injector versions
3 mRNA “vaccines” (Moderna + Korea University, Chinese research team, VIDO Canada)
2 viral vector “vaccines” (UK institutions + VIDO Canada)
1 inactivated vaccine (Hantavax — already licensed and used in South Korea)
1 protein subunit vaccine (VIDO Canada)

U.S. Army Quietly Developing Hantavirus Vaccines and Gene Therapies

The US Army hantavirus DNA “vaccines” are not vaccines. They are literally plasmid DNA gene-therapies. Each one contains lab-made circular DNA (plasmids) carrying the hantavirus M-segment genes that code for the virus’s surface glycoproteins (Gn and Gc). When injected (often with a needle-free jet injector or electroporation device), your own cells absorb the DNA, read it like a blueprint, and start manufacturing the pathogenic hantavirus proteins themselves.

Needless to say, I will NOT be lining up for experimental military-grade gene therapy the Army has been tinkering with for over 20 years.

I’d rather take my chances with the natural red algae protein Griffithsin:

The cruise ship situation should NOT become a pandemic. However, with major World Health Organization involvement, mass media claiming potentially infected passengers have now traveled to multiple countries, and the pre-existing 13-vaccine pipeline, the early stages are being set for hantavirus as the next plandemic operation.

Perhaps the hantavirus situation is being pushed hard because the WHO’s pandemic treaty negotiations hit a major roadblock just 5 days ago. Member states still can’t agree on the Pathogen Access and Benefit-Sharing (PABS) annex, meaning the pandemic treaty can’t come into effect. This clearly angered WHO Director-General Tedros Adhanom Ghebreyesus, prompting him to warn the next pandemic was “a matter of when, not if.”